돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 209생성일: 2026년 10월 23일

1-(Benzyloxy)-4-bromo-2-methoxybenzene → (3R)-1-(3-methoxy-4-phenylmethoxyphenyl)-3-methylpiperazine

https://huagongshe.com/ko/reaction/209

반응식

참여 물질

역할이름HCID투입량
반응물1-(Benzyloxy)-4-bromo-2-methoxybenzeneHCID 3613128—
반응물tert-Butyl (2R)-2-methylpiperazine-1-carboxylateHCID 10262201—
시약Sodium t-butoxideHCID 23676156—
촉매Binap, (A+-)-HCID 634876—
촉매Bis(dibenzylideneacetone)palladiumHCID 9811564—
용매TolueneHCID 1140—
생성물(3R)-1-(3-methoxy-4-phenylmethoxyphenyl)-3-methylpiperazineHCID 7027896040.26%

반응 조건

온도80 °C

반응 단계

To (R)-tert-butyl 2-methylpiperazine-1-carboxylate (0.717 g, 3.58 mmol), TRIS(DIBENZYLIDENEACETONE)DIPALLADIUM(0) (0.094 g, 0.10 mmol) and 2,2'-bis(diphenylphosphino)-1,1'-binaphthyl (0.085 g, 0.14 mmol) and Sodium tert-butoxide (0.459 g, 4.78 mmol) was added a solution of 1-(benzyloxy)-4-bromo-2-methoxybenzene (1 g, 3.41 mmol) in Toluene (25 mL). The reaction was heated to 80 °C for 18 hours. the reaction was allowed to cool to room temperature and diluted with dcm (50 ml). This was washed with water (2 x 50 ml), dried over sodium sulfate, filtered and the solvent removed under reduced pressure. The crude product was dissolved in hydrochloric acid solution in methanol (4N, 20 ml) and stirred at room temprature overnight. The solvent was removed under reduced pressure.The crude product was purified by ion exchange chromatography, using an SCX column. The desired product was eluted from the column using 7M NH3/MeOH and pure fractions were evaporated to dryness to afford (R)-1-(4-(benzyloxy)-3-methoxyphenyl)-3-methylpiperazine (0.429 g, 40.3 %) as a yellow gum.

출처 및 근거

출처 데이터셋750 AstraZeneca ELN dataset
ORD IDord-80551a125bb34e24a0d215f47bcdf5d9
출처 메모750 AstraZeneca ELN dataset